Abstract
Surprisingly, the discrete-time version of the general 1927 Kermack-McKendrick epidemic model has, to our knowledge, not been formulated in the literature, and we rectify this omission here. The discrete time version is as general and flexible as its continuous-time counterpart, and contains numerous compartmental models as special cases. In contrast to the continuous time version, the discrete time version of the model is very easy to implement computationally, and thus promises to become a powerful tool for exploring control scenarios for specific infectious diseases. To demonstrate the potential, we investigate numerically how the incidence-peak size depends on model ingredients. We find that, with the same reproduction number and initial speed of epidemic spread, compartmental models systematically predict lower peak sizes than models that use a fixed duration for the latent and infectious periods.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Dutch NWO.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.